Osteoporosis
Conditions
Keywords
cohort, osteoporosis, bone mineral density, Chinese
Brief summary
This is a multicenter cohort study on osteoporosis in nine cities of China which locate in the east, south, north, west, middle of China. At least 3000 middle-aged and elderly permanent residents (women aged from 45 to 79, and men aged from 50 to 79) in every city will be enrolled. Residents with severe mental diseases, physical diseases or acute infectious diseases who could not cooperate with the survey as well as lactating or pregnant women were excluded. All the enrolled residents who signed informed consent will finish questionnaire including demographic characteristics, history of smoking, alcohol drinking, falls and fracture, family genetic history, chronic diseases and medicine,diary and physical practice，stool and urine status. Osteoporosis risk, health status, constitution of traditional Chinese medicine (TCM),symptoms of kidney yang deficiency in TCM，living environment,sweating status will be evaluated. Fasting blood glucose test and other blood tests for liver and kidney function,bone metabolism，vitamins，vitamin D metabolism and transportation as well as calcium and phosphate metabolism, will be performed. Bone mineral density and physical examinations (height, weight, waist circumference, hip circumference,grip,sit-to-stand test, tongue coating and pulse) will also be performed at enrollment and every two years after enrollment. DNA of blood cells will be preserved for specific study such as SNP analyses.Tongue coating and feces will be preserved for microflora analyses.
Interventions
None listed
Sponsors
Wangjing Hospital, China Academy of Chinese Medical Sciences
Dongzhimen Hospital, Beijing
The First Affiliated Hospital of Guangzhou University of TCM
Guangdong Provincial Hospital of Traditional Chinese Medicine
Affiliated Hospital of Changchun University of Chinese Medicine
Gansu Provincial Hospital
Guangzhou Kingmed Diagnostics Co., Ltd.
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Yunnan Provincial Hospital of Traditional Chinese Medicine
Shenzhen Pingle Orthopedic Hospital
First People's Hospital of Nankang District, Ganzhou City
Shanghai University of Traditional Chinese Medicine
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
45 Years to 79 Years
Healthy volunteers
No
Inclusion criteria
* permanent residents * women aged from 45 to 79, and men aged from 50 to 79
Exclusion criteria
* severe mental diseases, physical diseases or acute infectious diseases who could not cooperate with the survey. * lactating or pregnant women.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| changes in bone mineral density from baseline to 2, 4, 6, 8 and 10 years after enrollment | at enrollment, and 2, 4, 6, 8 and 10 years after enrollment | lumbar (L1-4 as well as total) and hip bone mineral density will be recorded by dual energy X-ray absorptiometry. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| serum P | at enrollment, and 2, 4, 6, 8 and 10 years after enrollment | — |
| serum Mg | at enrollment, and 2, 4, 6, 8 and 10 years after enrollment | — |
| serum fibroblast growth factor (FGF)23 | at enrollment, and 2, 4, 6, 8 and 10 years after enrollment | — |
| fracture questionnaire | at enrollment, and 2, 4, 6, 8 and 10 years after enrollment | information about fracture including cause, time, skeletal site and therapy during the follow-up period will be collected through fracture questionnaire |
| serum osteocalcin | at enrollment, and 2, 4, 6, 8 and 10 years after enrollment | — |
| serum Ca | at enrollment, and 2, 4, 6, 8 and 10 years after enrollment | — |
| serum bone alkaline phosphatase (BALP) | at enrollment, and 2, 4, 6, 8 and 10 years after enrollment | — |
| serum β-crosslaps (β-CTX) | at enrollment, and 2, 4, 6, 8 and 10 years after enrollment | — |
| serum parathormone (PTH) | at enrollment, and 2, 4, 6, 8 and 10 years after enrollment | — |
| serum total 25(OH) vitamin D | at enrollment, and 2, 4, 6, 8 and 10 years after enrollment | — |
| serum procollagen type I N-terminal propeptide (PINP) | at enrollment, and 2, 4, 6, 8 and 10 years after enrollment | — |
Countries
China
Contacts
Primary ContactYongjun Wang
Outcome results
None listed